PLG Training Faculty

Jill has over 26 years’ experience in the biopharmaceutical, healthcare... and drug delivery industries, combining broad commercial experience with a strong scientific background.
Jill has a PhD in Genetics and spent five years in molecular biology research at the Universities of Edinburgh and Oxford. Jill has held various R&D and project management positions in the pharmaceutical industry and has been involved in numerous licensing, product and technology divestments and finalised a range of deals on early stage products and technology platforms.
Since 2007, Jill has been a business development consultant working for numerous international clients being involved in a range of transactions.
[More]

Sharon has more than 30 years proven experience in business... development having worked in-house at the Wellcome Foundation, Medeva plc and Ono Pharmaceutical Co. Ltd. prior to founding Medius Associates, a specialised pharma business development consultancy group in 1994.
Sharon has designed and ran in house BD training programmes covering a wide range of topics for the Pharmaceutical Industry and chairs the PLG ITC course. She is Editor of the Business Development & Licensing Journal and is also a past Chairman of the UK Pharmaceutical Licensing Group Ltd and a past President of the European PLG Council.
[More]

With over 20 years healthcare experience at global pharmaceutical company... AstraZeneca, BUPA Hospitals and the NHS, Jane Gaddum brings extensive experience in influencing decision-making in large complex organisations. Much of her career has been spent in the pharmaceutical industry, guiding product and corporate strategy and portfolio investment decisions at a global level, collaborating cross-culturally and cross functionally at the interface between Commercial, R&D and Business Development. She has held roles in emerging markets and global brand management; portfolio management across therapy areas; and as Vice President Emerging Brands, leading international marketing teams shaping the design, development and acquisition of new medicines for Asthma, COPD and Auto-immune diseases. She is passionate about ensuring the future needs of patients, physicians and those who fund healthcare, are built into phase 2 and 3 development plans.
Jane is currently a Non Executive Director and Chair of the Finance, Investment and Performance Committee for an NHS Trust, alongside running a textile business with a long trading history in silk yarns, bi-products and technical fibres. She also uses her extensive pharma experience on consultancy projects. Jane has a first degree in Agricultural Economics and an MBA from Henley Management College.
[More]

Catharine has a wide range of experience in the pharmaceutical... and biotechnology industries gained over twenty years working in health care consulting, banking and industry. She undertakes projects in a variety of areas and specialises in strategic assessments for acquisitions, portfolio reviews and project, deal and company valuations and is also experienced in supporting companies during fundraising activities.
Catharine has a degree in Genetics from Cambridge and an MBA from Insead. Catharine’s industry experience commenced with three years in the City at Robert Fleming’s broking division where she was an analyst covering European and US biotech stocks. She speaks French well and has a working knowledge of German and Italian.
[More]

Janet is a Solicitor and Registered Technology Transfer Professional and... has over 30 years’ experience of dealing with transactional IP in relation to all IP rights, but particularly in the science and technology fields. Janet is one of a limited number of UK IP licensing professionals recommended by the international guide IAM 1000 – Guide to the World’s Patent Practitioners (2018) and as an IP Star by Managing Intellectual Property.
Janet works with a wide range of clients but has particular expertise within the life sciences industry, in working with educational institutions and their spin-out companies and in the anti-trust issues of IP commercialisation.
Janet covers commercial life sciences transactions including their regulatory and IP implications. Her work ranges from early R&D phases and clinical trials to licensing, clinical and commercial manufacturing and supply and beyond. Her experience includes advising on: R&D, clinical trials and related CRO agreements; in-licensing; dossier and associated brand acquisitions.
[More]